Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
EULAR Rheumatology Open|June 29, 2026
Global perspectives on rheumatology training: insights from the EULAR 2025 EMEUNET Presents sessionLatika Gupta, Alexandros Panagiotopoulos, Dzifa Dey, et al.
Mediterranean Journal of Rheumatology|November 9, 2020
Mitophagy Balance in Various Cell Subsets in Patients with ANCA-Associated Vasculitis and Correlation with the Presence of Anti-Neutrophil Cytoplasmic AntibodiesAggelos Banos, Konstantinos Thomas, Panagiotis Garantziotis, et al.
Rheumatology International|February 25, 2023
Ixekizumab therapy following secukinumab inadequate response in psoriatic arthritis: a case series focusing on axial diseaseAlexandros Panagiotopoulos, Christos Koutsianas, Nikolaos Kougkas, et al.
Arthritis Research & Therapy|March 20, 2021
Serious infections in ANCA-associated vasculitides in the biologic era: real-life data from a multicenter cohort of 162 patientsKonstantinos Thomas, Evangelia Argyriou, Noemin Kapsala, et al.
Biomolecules|March 28, 2025
Liver Injury Following Intravenous Methylprednisolone Pulse Therapy in Multiple Sclerosis: The Experience from a Single Academic Liver CenterDimitris Kounatidis, Natalia G Vallianou, Georgios Kontos, et al.
Rheumatology (Oxford, England)|August 7, 2024
Relapses and serious adverse events during rituximab maintenance therapy in ANCA-associated vasculitis: a multicentre retrospective studyChrysoula G Gialouri, Aglaia Chalkia, Christos Koutsianas, et al.
Rheumatology International|March 29, 2024
Outcomes of COVID-19 re-infections: a single-center cohort of 167 patients with systemic rheumatic diseasesAlexandros Panagiotopoulos, George E Fragoulis, Aikaterini Arida, et al.
Annals of the Rheumatic Diseases|November 11, 2021
Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseasesCharalampos Papagoras, George E Fragoulis, Nikoleta Zioga, et al.
Clinical Rheumatology|September 21, 2023
Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseasesCharalampos Papagoras, Nikoleta Zioga, Vasileios Papadopoulos, et al.
Frontiers in Medicine|December 27, 2023
Efficacy of canakinumab in patients with Still's disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still's DiseaseAntonio Vitale, Valeria Caggiano, Petros P Sfikakis, et al.
Pageof 2